OptiBiotix Health Plc (AIM:OPTI)
London · Delayed Price · Currency is GBP · Price in GBX 5.88
+0.03 (0.43%)
Sep 25, 2026, 4:02 PM GMT
OptiBiotix Health Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.29 | 1.17 | 0.87 | 0.64 | 0.46 | 2.21 | |
Revenue Growth | 11.90% | 34.02% | 35.09% | 40.92% | -79.35% | 45.28% |
Cost of Revenue | 0.6 | 0.55 | 0.54 | 0.32 | 0.21 | 1.09 |
Gross Profit | 0.69 | 0.61 | 0.33 | 0.32 | 0.24 | 1.12 |
Selling, General & Admin | 2.83 | 3.43 | 2.3 | 1.79 | 2.51 | 2.2 |
Research & Development | 0.31 | 0.32 | 0.29 | 0.22 | - | - |
Operating Expenses | 3.14 | 3.75 | 2.6 | 2.02 | 2.73 | 2.49 |
Operating Income | -2.45 | -3.13 | -2.27 | -1.7 | -2.49 | -1.37 |
Interest Expense | - | - | - | - | - | -0.05 |
Interest & Investment Income | - | - | 0 | 0 | - | - |
Earnings From Equity Investments | -0.34 | -0.42 | -0.35 | -0.32 | -0.08 | - |
EBT Excluding Unusual Items | -2.79 | -3.55 | -2.62 | -2.02 | -2.57 | -1.41 |
Gain (Loss) on Sale of Investments | -1.57 | -0.39 | 0.75 | -0.03 | -16.63 | 7.59 |
Gain (Loss) on Sale of Assets | - | - | - | - | 21.65 | - |
Pretax Income | -4.36 | -3.94 | -1.87 | -2.04 | 2.44 | 6.18 |
Income Tax Expense | -0.07 | -0.05 | -0.06 | -0 | -0.15 | -0.08 |
Earnings From Continuing Operations | -4.29 | -3.89 | -1.81 | -2.04 | 2.59 | 6.26 |
Net Income | -4.29 | -3.89 | -1.81 | -2.04 | 2.59 | 6.26 |
Net Income to Common | -4.29 | -3.89 | -1.81 | -2.04 | 2.59 | 6.26 |
Net Income Growth | - | - | - | - | -58.68% | 7.91% |
Shares Outstanding (Basic) | 102 | 101 | 98 | 90 | 88 | 88 |
Shares Outstanding (Diluted) | 102 | 101 | 98 | 90 | 93 | 96 |
Shares Change | -0.20% | 3.37% | 8.55% | -3.24% | -2.43% | -0.03% |
EPS (Basic) | -0.04 | -0.04 | -0.02 | -0.02 | 0.03 | 0.07 |
EPS (Diluted) | -0.04 | -0.04 | -0.02 | -0.02 | 0.03 | 0.07 |
EPS Growth | - | - | - | - | -57.56% | 7.91% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.71 | -1.77 | -1.77 | -1.53 | -1.11 | -1.57 |
Free Cash Flow Per Share | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 |
Gross Margin | 53.65% | 52.66% | 38.05% | 49.69% | 53.39% | 50.75% |
Operating Margin | -190.06% | -268.61% | -260.46% | -263.35% | -544.64% | -61.68% |
Profit Margin | -332.69% | -333.62% | -207.47% | -316.62% | 566.08% | 282.92% |
Free Cash Flow Margin | -132.69% | -151.80% | -203.22% | -237.11% | -242.67% | -70.72% |
EBITDA | -2.24 | -2.93 | -2.06 | -1.49 | -2.27 | -1.08 |
EBITDA Margin | -173.91% | -251.03% | -236.44% | -231.52% | - | -48.67% |
D&A For EBITDA | 0.21 | 0.21 | 0.21 | 0.21 | 0.22 | 0.29 |
EBIT | -2.45 | -3.13 | -2.27 | -1.7 | -2.49 | -1.37 |
EBIT Margin | -190.06% | -268.61% | -260.46% | -263.35% | - | -61.68% |